Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Effectiveness of Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease: a Double-blind, Placebo-controlled Randomised Trial

NCT00880373 is registered in ClinicalTrials.gov with London North West Healthcare NHS Trust as lead sponsor.

NCT NCT00880373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00880373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Effectiveness of Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease: a Double-blind, Placebo-controlled Randomised Trial
Lead sponsor
London North West Healthcare NHS Trust
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2011
Completion date
August 31, 2014
Enrollment
320 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease